X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs GSK PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA GSK PHARMA ABBOTT INDIA/
GSK PHARMA
 
P/E (TTM) x 43.5 63.6 68.5% View Chart
P/BV x 10.9 10.2 106.4% View Chart
Dividend Yield % 0.6 1.2 49.8%  

Financials

 ABBOTT INDIA   GSK PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
GSK PHARMA
Mar-17
ABBOTT INDIA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs6,0153,838 156.7%   
Low Rs3,7072,637 140.6%   
Sales per share (Unadj.) Rs1,236.9354.2 349.2%  
Earnings per share (Unadj.) Rs122.239.8 307.3%  
Cash flow per share (Unadj.) Rs129.042.9 300.9%  
Dividends per share (Unadj.) Rs35.0030.00 116.7%  
Dividend yield (eoy) %0.70.9 77.7%  
Book value per share (Unadj.) Rs521.2236.9 220.0%  
Shares outstanding (eoy) m21.2584.70 25.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.99.1 43.0%   
Avg P/E ratio x39.881.4 48.9%  
P/CF ratio (eoy) x37.775.5 49.9%  
Price / Book Value ratio x9.313.7 68.3%  
Dividend payout %28.675.4 38.0%   
Avg Mkt Cap Rs m103,296274,216 37.7%   
No. of employees `0003.04.7 62.9%   
Total wages/salary Rs m3,3704,830 69.8%   
Avg. sales/employee Rs Th8,891.86,387.0 139.2%   
Avg. wages/employee Rs Th1,140.01,028.3 110.9%   
Avg. net profit/employee Rs Th878.3717.1 122.5%   
INCOME DATA
Net Sales Rs m26,28430,000 87.6%  
Other income Rs m504728 69.3%   
Total revenues Rs m26,78930,728 87.2%   
Gross profit Rs m3,6654,190 87.5%  
Depreciation Rs m144263 54.9%   
Interest Rs m80-   
Profit before tax Rs m4,0174,655 86.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m1,4211,744 81.5%   
Profit after tax Rs m2,5963,368 77.1%  
Gross profit margin %13.914.0 99.9%  
Effective tax rate %35.437.5 94.4%   
Net profit margin %9.911.2 88.0%  
BALANCE SHEET DATA
Current assets Rs m14,44616,742 86.3%   
Current liabilities Rs m4,7257,202 65.6%   
Net working cap to sales %37.031.8 116.3%  
Current ratio x3.12.3 131.5%  
Inventory Days Days5152 99.2%  
Debtors Days Days2021 94.1%  
Net fixed assets Rs m1,1138,635 12.9%   
Share capital Rs m213847 25.1%   
"Free" reserves Rs m10,80819,222 56.2%   
Net worth Rs m11,07620,069 55.2%   
Long term debt Rs m010 0.0%   
Total assets Rs m16,24130,038 54.1%  
Interest coverage x497.0NM-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.61.0 162.0%   
Return on assets %16.011.2 143.0%  
Return on equity %23.416.8 139.7%  
Return on capital %36.325.5 142.7%  
Exports to sales %0.60-   
Imports to sales %12.60-   
Exports (fob) Rs m162NA-   
Imports (cif) Rs m3,322NA-   
Fx inflow Rs m268528 50.8%   
Fx outflow Rs m3,9277,193 54.6%   
Net fx Rs m-3,659-6,665 54.9%   
CASH FLOW
From Operations Rs m2,5142,360 106.5%  
From Investments Rs m-8003,008 -26.6%  
From Financial Activity Rs m-803-5,108 15.7%  
Net Cashflow Rs m912260 350.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 50.7 147.9%  
Indian inst/Mut Fund % 7.9 10.2 77.5%  
FIIs % 0.1 23.8 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 15.4 111.0%  
Shareholders   18,270 102,036 17.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 19, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS